JOHN JOHN: Open Payments
NPI 1497789507 · WARREN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 25 payments from 10 companies in 2025. Trend: 2023 $483 · 2024 $610 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 6 | $124 |
| Alkermes, Inc. | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Novo Nordisk Inc | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
Products named: REXULTI, LYBALVI, INVEGA SUSTENNA, INGREZZA, TRINTELLIX, AUSTEDO XR, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across PA — which companies pay providers there.
